NASDAQ:HLNE - Nasdaq - US4074971064 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to HLNE. HLNE was compared to 230 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making HLNE a very profitable company, without any liquidiy or solvency issues. HLNE is valued quite expensive, but it does show an excellent growth. This makes HLNE very considerable for growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 13.53% | ||
ROE | 33.16% | ||
ROIC | 20.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 45.75% | ||
PM (TTM) | 31.13% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.45 | ||
Debt/FCF | 1.07 | ||
Altman-Z | 7.33 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.24 | ||
Quick Ratio | 1.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 31.75 | ||
Fwd PE | 33.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 33.65 | ||
EV/EBITDA | 27.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.15% |
165.41
+1.55 (+0.95%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.15% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 31.75 | ||
Fwd PE | 33.97 | ||
P/S | 13.28 | ||
P/FCF | 33.65 | ||
P/OCF | 32.42 | ||
P/B | 14.14 | ||
P/tB | 14.14 | ||
EV/EBITDA | 27.83 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 13.53% | ||
ROE | 33.16% | ||
ROCE | 26.45% | ||
ROIC | 20.87% | ||
ROICexc | 28.54% | ||
ROICexgc | 29.5% | ||
OM | 45.75% | ||
PM (TTM) | 31.13% | ||
GM | N/A | ||
FCFM | 39.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.45 | ||
Debt/FCF | 1.07 | ||
Debt/EBITDA | 0.9 | ||
Cap/Depr | 108.93% | ||
Cap/Sales | 1.49% | ||
Interest Coverage | 250 | ||
Cash Conversion | 86.92% | ||
Profit Quality | 126.78% | ||
Current Ratio | 1.24 | ||
Quick Ratio | 1.24 | ||
Altman-Z | 7.33 |